Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study

Charles J. Brainerd, Valerie F. Reyna, Ronald Carl Petersen, Glenn E. Smith, Emily S. Taub

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: Although the e{open}4 allele of the apolipoprotein E (APOE) genotype is a known risk factor for Alzheimer's dementia (AD), prior findings on whether it is also a risk factor for mild cognitive impairment (MCI) have been inconsistent. We tested two contrasting explanations: (a) an e{open}4-AD specificity hypothesis, and (b) a measurement insensitivity hypothesis. Method: The frequency of the e{open}4 allele was investigated in older adults (mean age > 70) with various types of cognitive impairment (including MCI) and various types of dementia (including AD) with the aging, demographics, and memory study (ADAMS) of the National Institute on Aging's Health and Retirement Study (HRS). The ADAMS controls sources of Type I and Type II error that are posited in the e{open}4-AD specificity hypothesis and the measurement insensitivity hypothesis, and it is the only nationally representative data set on aging and cognitive impairment. Results: e{open}4 was a reliable predictor of MCI, with a frequency of 32% in MCI subjects versus 20% in healthy control subjects. This link was specific to MCI because e{open}4 was not a risk factor for other forms of cognitive impairment without dementia. Conclusions: The results support the measurement insensitivity hypothesis rather than the e{open}4-AD specificity hypothesis and are consistent with recent research showing modest reductions in cognitive performance among normal functioning e{open}4 carriers.

Original languageEnglish (US)
Pages (from-to)679-689
Number of pages11
JournalNeuropsychology
Volume25
Issue number6
DOIs
StatePublished - Nov 2011

Fingerprint

Apolipoproteins E
Biomarkers
Genotype
Alzheimer Disease
Population Dynamics
Dementia
National Institute on Aging (U.S.)
Alleles
Apolipoprotein E4
Cognitive Dysfunction
Mild Cognitive Impairment
Retirement
Alzheimer
Healthy Volunteers
Health
Specificity
Risk Factors
Cognitive Impairment
Research

Keywords

  • Alzheimer's dementia
  • APOE genotype
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Arts and Humanities (miscellaneous)

Cite this

Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study. / Brainerd, Charles J.; Reyna, Valerie F.; Petersen, Ronald Carl; Smith, Glenn E.; Taub, Emily S.

In: Neuropsychology, Vol. 25, No. 6, 11.2011, p. 679-689.

Research output: Contribution to journalArticle

Brainerd, Charles J. ; Reyna, Valerie F. ; Petersen, Ronald Carl ; Smith, Glenn E. ; Taub, Emily S. / Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study. In: Neuropsychology. 2011 ; Vol. 25, No. 6. pp. 679-689.
@article{3450354ec9164c22b908fd2e57b95776,
title = "Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study",
abstract = "Objective: Although the e{open}4 allele of the apolipoprotein E (APOE) genotype is a known risk factor for Alzheimer's dementia (AD), prior findings on whether it is also a risk factor for mild cognitive impairment (MCI) have been inconsistent. We tested two contrasting explanations: (a) an e{open}4-AD specificity hypothesis, and (b) a measurement insensitivity hypothesis. Method: The frequency of the e{open}4 allele was investigated in older adults (mean age > 70) with various types of cognitive impairment (including MCI) and various types of dementia (including AD) with the aging, demographics, and memory study (ADAMS) of the National Institute on Aging's Health and Retirement Study (HRS). The ADAMS controls sources of Type I and Type II error that are posited in the e{open}4-AD specificity hypothesis and the measurement insensitivity hypothesis, and it is the only nationally representative data set on aging and cognitive impairment. Results: e{open}4 was a reliable predictor of MCI, with a frequency of 32{\%} in MCI subjects versus 20{\%} in healthy control subjects. This link was specific to MCI because e{open}4 was not a risk factor for other forms of cognitive impairment without dementia. Conclusions: The results support the measurement insensitivity hypothesis rather than the e{open}4-AD specificity hypothesis and are consistent with recent research showing modest reductions in cognitive performance among normal functioning e{open}4 carriers.",
keywords = "Alzheimer's dementia, APOE genotype, Mild cognitive impairment",
author = "Brainerd, {Charles J.} and Reyna, {Valerie F.} and Petersen, {Ronald Carl} and Smith, {Glenn E.} and Taub, {Emily S.}",
year = "2011",
month = "11",
doi = "10.1037/a0024483",
language = "English (US)",
volume = "25",
pages = "679--689",
journal = "Neuropsychology",
issn = "0894-4105",
publisher = "American Psychological Association Inc.",
number = "6",

}

TY - JOUR

T1 - Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study

AU - Brainerd, Charles J.

AU - Reyna, Valerie F.

AU - Petersen, Ronald Carl

AU - Smith, Glenn E.

AU - Taub, Emily S.

PY - 2011/11

Y1 - 2011/11

N2 - Objective: Although the e{open}4 allele of the apolipoprotein E (APOE) genotype is a known risk factor for Alzheimer's dementia (AD), prior findings on whether it is also a risk factor for mild cognitive impairment (MCI) have been inconsistent. We tested two contrasting explanations: (a) an e{open}4-AD specificity hypothesis, and (b) a measurement insensitivity hypothesis. Method: The frequency of the e{open}4 allele was investigated in older adults (mean age > 70) with various types of cognitive impairment (including MCI) and various types of dementia (including AD) with the aging, demographics, and memory study (ADAMS) of the National Institute on Aging's Health and Retirement Study (HRS). The ADAMS controls sources of Type I and Type II error that are posited in the e{open}4-AD specificity hypothesis and the measurement insensitivity hypothesis, and it is the only nationally representative data set on aging and cognitive impairment. Results: e{open}4 was a reliable predictor of MCI, with a frequency of 32% in MCI subjects versus 20% in healthy control subjects. This link was specific to MCI because e{open}4 was not a risk factor for other forms of cognitive impairment without dementia. Conclusions: The results support the measurement insensitivity hypothesis rather than the e{open}4-AD specificity hypothesis and are consistent with recent research showing modest reductions in cognitive performance among normal functioning e{open}4 carriers.

AB - Objective: Although the e{open}4 allele of the apolipoprotein E (APOE) genotype is a known risk factor for Alzheimer's dementia (AD), prior findings on whether it is also a risk factor for mild cognitive impairment (MCI) have been inconsistent. We tested two contrasting explanations: (a) an e{open}4-AD specificity hypothesis, and (b) a measurement insensitivity hypothesis. Method: The frequency of the e{open}4 allele was investigated in older adults (mean age > 70) with various types of cognitive impairment (including MCI) and various types of dementia (including AD) with the aging, demographics, and memory study (ADAMS) of the National Institute on Aging's Health and Retirement Study (HRS). The ADAMS controls sources of Type I and Type II error that are posited in the e{open}4-AD specificity hypothesis and the measurement insensitivity hypothesis, and it is the only nationally representative data set on aging and cognitive impairment. Results: e{open}4 was a reliable predictor of MCI, with a frequency of 32% in MCI subjects versus 20% in healthy control subjects. This link was specific to MCI because e{open}4 was not a risk factor for other forms of cognitive impairment without dementia. Conclusions: The results support the measurement insensitivity hypothesis rather than the e{open}4-AD specificity hypothesis and are consistent with recent research showing modest reductions in cognitive performance among normal functioning e{open}4 carriers.

KW - Alzheimer's dementia

KW - APOE genotype

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=82855171505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82855171505&partnerID=8YFLogxK

U2 - 10.1037/a0024483

DO - 10.1037/a0024483

M3 - Article

C2 - 21728427

AN - SCOPUS:82855171505

VL - 25

SP - 679

EP - 689

JO - Neuropsychology

JF - Neuropsychology

SN - 0894-4105

IS - 6

ER -